ArticleInternational journal of clinical oncology2024

Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.

Ayumu Mitsuyoshi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.